Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on July 24, 2003; DOI 10.1182/blood-2003-03-0703.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-03-0703v1
102/10/3702    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sprong, T.
Right arrow Articles by Mollnes, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sprong, T.
Right arrow Articles by Mollnes, T. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted March 7, 2003
Accepted July 14, 2003

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis

Tom Sprong*, Petter Brandtzaeg, Michael Fung, Anne M Pharo, E Arne Hoiby, Terje E Michaelsen, Audun Aase, Jos W M van der Meer, Marcel van Deuren, and Tom Eirik Mollnes

Department of General Internal Medicine, University Medical Centre St Radboud, Nijmegen, The Netherlands
Department of Pediatrics, Ullevaal University Hospital, Oslo, Norway
Tanox Inc., Houston, TX, USA
Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway
Norwegian Institute of Public Health, Oslo, Norway
Department of Pharmacognosy, Institute of Pharmacy, University of Oslo, Oslo, Norway

* Corresponding author; email: tsprong{at}aig.umcn.nl.

The complement system plays an important role in the initial defence against Neisseria meningitidis. In contrast, uncontrolled activation in meningococcal sepsis contributes to development of tissue damage and shock. In a novel human whole blood model of meningococcal sepsis we studied the effect of complement inhibition on inflammation and bacterial killing. Monoclonal antibodies (mAb) blocking lectin and/or alternative pathways inhibited complement activation by Neisseria meningitidis and oxidative burst induced in granulocytes and monocytes. Oxidative burst was critically dependent on CD11b/CD18 (CR3) expression, but not on Fc{gamma}-receptors. Specific inhibition of C5a using mAb 137-26 binding the C5a moiety of C5 before cleavage, prohibited CR3 upregulation, phagocytosis and oxidative burst, but had no effect on C5b-9 (TCC) formation, lysis and bacterial killing. A mAb blocking cleavage of C5, preventing C5a and TCC formation, showed the same effect on CR3, phagocytosis and oxidative burst as the anti-C5a mAb, but additionally inhibited TCC formation, lysis and bacterial killing, consistent with a C5b-9 dependent killing mechanism. In conclusion, the anti-C5a mAb 137-26 inhibits the potentially harmful effects of Neisseria meningitidis-induced C5a formation while preserving complement-mediated bacterial killing. We suggest that this may be an attractive approach for treatment of meningococcal sepsis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CVIHome page
J. S. Plested, J. A. Welsch, and D. M. Granoff
Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity
Clin. Vaccine Immunol., June 1, 2009; 16(6): 785 - 791.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. B. Thorgersen, A. Pharo, K. Haverson, A. K. Axelsen, P. Gaustad, G. J. Kotwal, G. Sfyroera, and T. E. Mollnes
Inhibition of Complement and CD14 Attenuates the Escherichia coli-Induced Inflammatory Response in Porcine Whole Blood
Infect. Immun., February 1, 2009; 77(2): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. A. Flierl, D. Rittirsch, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, and P. A. Ward
Functions of the complement components C3 and C5 during sepsis
FASEB J, October 1, 2008; 22(10): 3483 - 3490.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. A. Welsch and D. Granoff
Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal Antibody
Clin. Vaccine Immunol., December 1, 2007; 14(12): 1596 - 1602.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
O.-L. Brekke, D. Christiansen, H. Fure, M. Fung, and T. E. Mollnes
The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood
J. Leukoc. Biol., June 1, 2007; 81(6): 1404 - 1413.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Sprong, D. Roos, C. Weemaes, C. Neeleman, C. L. M. Geesing, T. E. Mollnes, and M. van Deuren
Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections
Blood, June 15, 2006; 107(12): 4865 - 4870.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Plant, H. Wan, and A.-B. Jonsson
MyD88-Dependent Signaling Affects the Development of Meningococcal Sepsis by Nonlipooligosaccharide Ligands.
Infect. Immun., June 1, 2006; 74(6): 3538 - 3546.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Sprong, A.-S. W. Moller, A. Bjerre, E. Wedege, P. Kierulf, J. W. M. van der Meer, P. Brandtzaeg, M. van Deuren, and T. E. Mollnes
Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide
Infect. Immun., June 1, 2004; 72(6): 3344 - 3349.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020